New Sandoz Board of Directors appointed Ruchika Sharma15 May 2023 9:27 AM GMTBasel: The Novartis Board of Directors has approved the recommendations of the Sandoz Chairman-designate, Gilbert Ghostine, on the structure of the...
Sandoz strengthens pipeline expansion through partnership to develop, manufacture multiple biosimilars Ruchika Sharma10 May 2023 10:00 AM GMTBasel: Sandoz has announced a multi-year partnership with Just - Evotec Biologics, the Seattle-based subsidiary of Evotec SE. The agreement covers the...
Novartis division Sandoz to exclusively commercialize six products in US across key therapeutic areas Ruchika Sharma4 May 2023 12:10 PM GMTBasel: Sandoz has announced that it has signed a distribution and collaboration agreement with Adalvo for exclusive Sandoz rights to commercialize six...
Patent infringement: Amgen sues Novartis to block generic osteoporosis, bone cancer drugs Ruchika Sharma3 May 2023 12:00 PM GMTAmgen said the proposed biosimilars infringe 21 patents covering Prolia and Xgeva.
Novartis lifts full year earnings on higher prescriptions Ruchika Sharma25 April 2023 6:07 AM GMTFirst-quarter group sales gained 3 percent to $12.95 billion, above an analyst consensus of $12.55 billion, driven by better than expected revenues...
Amgen wins patent appeal on psoriasis drug Otzela against Zydus Pharma (USA), Sandoz Ruchika Sharma22 April 2023 8:00 AM GMTThousand Oaks: Amgen has announced that the U.S. Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District...
Sandoz gets European Commission nod for Hyrimoz high-concentration formulation Ruchika Sharma4 April 2023 8:30 AM GMTAdalimumab is a human immunoglobulin G1 (IgG(1)) monoclonal antibody targeting tumor necrosis factor alpha (TNF-a).
USFDA nod to citrate free high concentration formulation of biosimilar Hyrimoz injection: Sandoz Ruchika Sharma22 March 2023 8:15 AM GMTSandoz intends to launch the Hyrimoz citrate-free HCF in the US on July 1, 2023.
Novartis names Gilbert Ghostine as Chairman designate of Sandoz Board of Directors Ruchika Sharma20 Feb 2023 10:00 AM GMTGhostine is an experienced business leader with a track record of growing and transforming businesses in competitive industries.
USFDA accepts Biologics License Application for proposed biosimilar denosumab: Sandoz Ruchika Sharma7 Feb 2023 4:45 AM GMTDenosumab is a human monoclonal antibody designed to bind to the RANKL protein, an activator of osteoclasts (cells involved in breaking down bone...
Novartis division Sandoz to set up Global Capability Centre in Hyderabad MD Bureau1 Feb 2023 8:00 AM GMTThe centre will initially have a workforce of 800 employees, with plans to increase to approximately 1,800 people in the near future.
Operating profit to grow again ahead of Sandoz spin off: Novartis Ruchika Sharma1 Feb 2023 4:30 AM GMTNovartis said in its statement it's on track to spin off its generics unit Sandoz in the second half of the year as part of its effort to sharpen its...
